Drug intelligence / Profile preview

diosmectite (Ipsen)

Development stage
Unknown
Lead developer
Ipsen
Modality
Small Molecules
Administration
Oral
01

Overview

Diosmectite (often referred to by its mineral constituent, montmorillonite) is a natural aluminomagnesium silicate clay used as an oral intestinal adsorbent. It is primarily indicated for the symptomatic treatment of acute diarrhea in children and adults, as well as chronic diarrhea and pain associated with functional bowel diseases. The drug's mechanism of action is physical; its layered phyllosilicate structure and high plastic viscosity allow it to coat the gastrointestinal mucosa, interacting with mucus glycoproteins to stabilize the protective barrier against pathogens, toxins, and irritants. Furthermore, it possesses significant non-specific adsorbent properties, binding to bacterial toxins, viruses (such as rotavirus), and bile salts within the gut lumen to facilitate their excretion. During the COVID-19 pandemic, diosmectite was investigated in clinical trials to manage gastrointestinal manifestations of SARS-CoV-2 infection, aiming to reduce diarrhea duration and potentially limit fecal-oral transmission by adsorbing viral particles.

Brand names
SmectaDio-2Dio2Dio 2SmecditeBosemectite
Other names
montmorillonitemontmorrillonitealuminum magnesium silicatebeidellitic montmorillonite
02

Targets

MUC5AC (Mucin-5AC)

Beyond the preview

Go deeper on diosmectite (Ipsen).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diosmectite (Ipsen).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call